BTLA / CD272 Reference Antibody (Tifcemalimab)

CAT: 0013-GTR18315633Size: 100 µgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR18315633Size:100 µg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Recombinant Antibody

Product Name Alternative

B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein, CD272, BTLA {ECO:0000303|PubMed:12796776, ECO:0000312|HGNC:HGNC:21087}

UniProt

Q7Z6A9

Reactivity

Human

Target

BTLA {ECO:0000303|PubMed:12796776, ECO:0000312|HGNC:HGNC:21087}

Clonality

Monoclonal

Conjugation

Unconjugated

Sequence

BTLA / CD272

Field of Research

Immunology & Inflammation

Concentration

1mg/ml

Form

Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column.

Molecular Weight

146 Da

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles

Notes

For research use only.

Tested Applications

FC, Kinetics

Isotype

IgG4

Related Products

Catalog	Name
GTR18780799-01	(Tifcemalimab) Biosimilar Reference Antibody
GTR18568255	CD272 (BTLA) Antibody
GTR18574773	BTLA Antibody / CD272
GTR18224673	BTLA/CD272 Antibody
GTR18222118	BTLA/CD272 Antibody
GTR18082612-01	BTLA Antibody / CD272
GTR18226267	BTLA/CD272 Antibody
GTR18222044	BTLA/CD272 Antibody
GTR18311611-01	BTLA/CD272 Antibody
GTR18612642-01	Mouse BTLA/CD272 Antibody

Catalog	Name
MBS9247138-01	Anti-BTLA/CD272 Reference Antibody (Tifcemalimab)
M03149-4	Anti-BTLA / CD272 Reference Antibody (Tifcemalimab)
E55B0439	Tifcemalimab (Reference antibody)
F1387-5	Anti-BTLA/CD272 Antibody (Tifcemalimab)
RA0040-01	Tifcemalimab (Biosimilar Reference Antibody) (BTLA)
M03149-3	Anti-BTLA / CD272 Reference Antibody (icatolimab)
MBS9246897-01	Anti-BTLA/CD272 Reference Antibody (icatolimab)
HV375076-01	Anti-Human CD272/BTLA Reference Antibody (Radanstobart, RUO)
047916	BTLA/CD272 (Tifcemalimab) discontinued
250587	CD272 Antibody